{"id":52917,"date":"2026-11-19T14:22:07","date_gmt":"2026-11-19T14:22:07","guid":{"rendered":"https:\/\/allonlinebanglanewspapers.com\/news\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\/"},"modified":"2026-11-19T14:22:07","modified_gmt":"2026-11-19T14:22:07","slug":"insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch","status":"publish","type":"post","link":"https:\/\/allonlinebanglanewspapers.com\/news\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\/","title":{"rendered":"InSitu Biologics Announces Completion of INSB200\u2122 GMP Manufacturing Batch"},"content":{"rendered":"<div id=\"main-body-container\" itemprop=\"articleBody\">\n<p>OAKDALE, Minn., Nov.  19, 2026  (GLOBE NEWSWIRE) &#8212; InSitu Biologics, Inc., a life sciences company developing proprietary injectable sustained-release drug-delivery technologies, today announced the successful completion of a Good Manufacturing Practice (GMP) production batch of its lead product candidate, INSB200\u2122.<\/p>\n<p>The completed GMP batch will support InSitu\u2019s planned December 2026 submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA), a key milestone toward initiating first-in-human clinical trials of INSB200\u2122.<\/p>\n<p>\u201cThe successful completion of GMP manufacturing represents a significant milestone, bringing us closer to our IND submission and first-in human clinical evaluation of INSB200,\u201d said Dan Halpern, CEO of InSitu Biologics.<\/p>\n<p>INSB200 is an investigational, single-injection, sustained-release peripheral nerve block (PNB) utilizing ropivacaine, a well-established local anesthetic, as a component of InSitu Biologics\u2019 proprietary drug-delivery platform. Administered at the time of surgery, INSB200\u2122 is designed to form a localized reservoir that gradually releases the non-opioid post-surgical pain relief over multiple days.<\/p>\n<p>Unlike conventional nerve blocks, which typically provide pain relief for 12\u201324 hours, INSB200\u2122\u00a0was developed to extend the duration of pain control while minimizing systemic drug exposure. The product allows motor muscle function to return within 12\u201318 hours while maintaining prolonged pain relief and reducing the need for opioid medications.<\/p>\n<p>InSitu Biologics is pursuing a 505(b)(2) regulatory pathway for INSB200\u2122, leveraging existing safety data for ropivacaine while evaluating the safety and efficacy of its proprietary sustained-release formulation. The Company anticipates FDA clearance of its IND application and initiation of its first-in-human combined Phase 1\/2 clinical trial in bunionectomy patients during Q1 2027. The trial will evaluate dosing, safety, and preliminary efficacy in managing post-surgical pain.<\/p>\n<p><strong>About InSitu Biologics<\/strong><\/p>\n<p>InSitu Biologics is life sciences company developing proprietary injectable sustained-release drug-delivery technologies. Its lead product candidate, INSB200\u2122, is an investigational, ropivacaine-based peripheral nerve block designed to provide prolonged, localized non-opioid post-surgical pain relief. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=m7utmSp843NicXk7KzYOttoLNgnmhttsQWWwbLTwkJryS0E8QYSSm1-nf9KPhH7GR68vVdM56itFVWxmUxDgFMHEbm6wJU1ntLuWFhrDN10=\" rel=\"nofollow\" target=\"_blank\" title=\"\"><u>www.insitubiologics.com<\/u><\/a>.<\/p>\n<p><strong>Media\/Investor Contact<\/strong><\/p>\n<p>Sandi Klemann<br \/>CFO, InSitu Biologics<br \/>sandi.klemann@insitubiologics.com | 651-419-6551<\/p>\n<p><em>This press release contains forward-looking statements, regarding InSitu Biologics\u2019 development plans for INSB200<\/em><em>\u2122<\/em><em>, including the anticipated timing of IND submission and FDA clearance, initiation of clinical trials, expected clinical outcomes, and potential therapeutic benefits. These statements are based on current expectations and are subject to risks and uncertainties, including regulatory review, clinical development, manufacturing, and financing risks, that could cause actual results to differ materially from those expressed or implied. InSitu Biologics undertakes no obligation to update these statements, except as required by applicable law.<\/em><\/p>\n<p><em>INSB200\u2122 is an investigational drug product that has not been approved by the U.S. Food and Drug Administration or any other regulatory authority. Its safety and efficacy have not yet been established.<\/em><\/p>\n<p>\n            <\/div>\n","protected":false},"excerpt":{"rendered":"<p>OAKDALE, Minn., Nov. 19, 2026 (GLOBE NEWSWIRE) &#8212; InSitu Biologics, Inc., a life sciences company developing proprietary injectable sustained-release drug-delivery technologies, today announced the successful completion of a Good Manufacturing Practice (GMP) production batch of its lead product candidate, INSB200\u2122. The completed GMP batch will support InSitu\u2019s planned December 2026 submission of an Investigational New [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":52918,"comment_status":"","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"fifu_image_url":"https:\/\/ml.globenewswire.com\/Resource\/Download\/575a465d-1d3f-4b72-915b-79015161d730","fifu_image_alt":"","footnotes":""},"categories":[11],"tags":[],"class_list":["post-52917","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-globenewswire"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.5.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"OAKDALE, Minn., Nov. 19, 2026 (GLOBE NEWSWIRE) -- InSitu Biologics, Inc., a life sciences company developing proprietary injectable sustained-release drug-delivery technologies, today announced the successful completion of a Good Manufacturing Practice (GMP) production batch of its lead product candidate, INSB200\u2122. The completed GMP batch will support InSitu\u2019s planned December 2026 submission of an Investigational New\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"Gias Ul Hassan\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/allonlinebanglanewspapers.com\/news\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\/\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.5.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"All Online Bangla Newspapers - Daily online newspapers Bangla, Bangla News online, All Bangla Newspaper, All online Bangla news\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"InSitu Biologics Announces Completion of INSB200\u2122 GMP Manufacturing Batch\" \/>\n\t\t<meta property=\"og:description\" content=\"OAKDALE, Minn., Nov. 19, 2026 (GLOBE NEWSWIRE) -- InSitu Biologics, Inc., a life sciences company developing proprietary injectable sustained-release drug-delivery technologies, today announced the successful completion of a Good Manufacturing Practice (GMP) production batch of its lead product candidate, INSB200\u2122. The completed GMP batch will support InSitu\u2019s planned December 2026 submission of an Investigational New\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/allonlinebanglanewspapers.com\/news\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/allonlinebanglanewspapers.com\/news\/wp-content\/uploads\/2023\/11\/Daily-Bangla-News.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/allonlinebanglanewspapers.com\/news\/wp-content\/uploads\/2023\/11\/Daily-Bangla-News.png\" \/>\n\t\t<meta property=\"og:image:width\" content=\"299\" \/>\n\t\t<meta property=\"og:image:height\" content=\"86\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-11-19T14:22:07+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-11-19T14:22:07+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"InSitu Biologics Announces Completion of INSB200\u2122 GMP Manufacturing Batch\" \/>\n\t\t<meta name=\"twitter:description\" content=\"OAKDALE, Minn., Nov. 19, 2026 (GLOBE NEWSWIRE) -- InSitu Biologics, Inc., a life sciences company developing proprietary injectable sustained-release drug-delivery technologies, today announced the successful completion of a Good Manufacturing Practice (GMP) production batch of its lead product candidate, INSB200\u2122. The completed GMP batch will support InSitu\u2019s planned December 2026 submission of an Investigational New\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/allonlinebanglanewspapers.com\/news\/wp-content\/uploads\/2023\/11\/Daily-Bangla-News.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\\\/#blogposting\",\"name\":\"InSitu Biologics Announces Completion of INSB200\\u2122 GMP Manufacturing Batch\",\"headline\":\"InSitu Biologics Announces Completion of INSB200\\u2122 GMP Manufacturing Batch\",\"author\":{\"@id\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/author\\\/giasulhassan\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/ml.globenewswire.com\\\/Resource\\\/Download\\\/575a465d-1d3f-4b72-915b-79015161d730\"},\"datePublished\":\"2026-11-19T14:22:07+00:00\",\"dateModified\":\"2026-11-19T14:22:07+00:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\\\/#webpage\"},\"articleSection\":\"GlobeNewsWire\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/category\\\/globenewswire\\\/#listItem\",\"name\":\"GlobeNewsWire\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/category\\\/globenewswire\\\/#listItem\",\"position\":2,\"name\":\"GlobeNewsWire\",\"item\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/category\\\/globenewswire\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\\\/#listItem\",\"name\":\"InSitu Biologics Announces Completion of INSB200\\u2122 GMP Manufacturing Batch\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\\\/#listItem\",\"position\":3,\"name\":\"InSitu Biologics Announces Completion of INSB200\\u2122 GMP Manufacturing Batch\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/category\\\/globenewswire\\\/#listItem\",\"name\":\"GlobeNewsWire\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/#organization\",\"name\":\"All Online Bangla Newspapers\",\"description\":\"Daily online newspapers Bangla, Bangla News online, All Bangla Newspaper, All online Bangla news\",\"url\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/wp-content\\\/uploads\\\/2023\\\/11\\\/Daily-Bangla-News.png\",\"@id\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\\\/#organizationLogo\",\"width\":299,\"height\":86,\"caption\":\"Daily Bangla News\"},\"image\":{\"@id\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\\\/#organizationLogo\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/author\\\/giasulhassan\\\/#author\",\"url\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/author\\\/giasulhassan\\\/\",\"name\":\"Gias Ul Hassan\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\\\/#webpage\",\"url\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\\\/\",\"name\":\"InSitu Biologics Announces Completion of INSB200\\u2122 GMP Manufacturing Batch\",\"description\":\"OAKDALE, Minn., Nov. 19, 2026 (GLOBE NEWSWIRE) -- InSitu Biologics, Inc., a life sciences company developing proprietary injectable sustained-release drug-delivery technologies, today announced the successful completion of a Good Manufacturing Practice (GMP) production batch of its lead product candidate, INSB200\\u2122. The completed GMP batch will support InSitu\\u2019s planned December 2026 submission of an Investigational New\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/author\\\/giasulhassan\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/author\\\/giasulhassan\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/ml.globenewswire.com\\\/Resource\\\/Download\\\/575a465d-1d3f-4b72-915b-79015161d730\",\"@id\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\\\/#mainImage\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\\\/#mainImage\"},\"datePublished\":\"2026-11-19T14:22:07+00:00\",\"dateModified\":\"2026-11-19T14:22:07+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/#website\",\"url\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/\",\"name\":\"All Online Bangla Newspapers\",\"description\":\"Daily online newspapers Bangla, Bangla News online, All Bangla Newspaper, All online Bangla news\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/allonlinebanglanewspapers.com\\\/news\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"InSitu Biologics Announces Completion of INSB200\u2122 GMP Manufacturing Batch","description":"OAKDALE, Minn., Nov. 19, 2026 (GLOBE NEWSWIRE) -- InSitu Biologics, Inc., a life sciences company developing proprietary injectable sustained-release drug-delivery technologies, today announced the successful completion of a Good Manufacturing Practice (GMP) production batch of its lead product candidate, INSB200\u2122. The completed GMP batch will support InSitu\u2019s planned December 2026 submission of an Investigational New","canonical_url":"https:\/\/allonlinebanglanewspapers.com\/news\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/allonlinebanglanewspapers.com\/news\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\/#blogposting","name":"InSitu Biologics Announces Completion of INSB200\u2122 GMP Manufacturing Batch","headline":"InSitu Biologics Announces Completion of INSB200\u2122 GMP Manufacturing Batch","author":{"@id":"https:\/\/allonlinebanglanewspapers.com\/news\/author\/giasulhassan\/#author"},"publisher":{"@id":"https:\/\/allonlinebanglanewspapers.com\/news\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/ml.globenewswire.com\/Resource\/Download\/575a465d-1d3f-4b72-915b-79015161d730"},"datePublished":"2026-11-19T14:22:07+00:00","dateModified":"2026-11-19T14:22:07+00:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/allonlinebanglanewspapers.com\/news\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\/#webpage"},"isPartOf":{"@id":"https:\/\/allonlinebanglanewspapers.com\/news\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\/#webpage"},"articleSection":"GlobeNewsWire"},{"@type":"BreadcrumbList","@id":"https:\/\/allonlinebanglanewspapers.com\/news\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/allonlinebanglanewspapers.com\/news\/#listItem","position":1,"name":"Home","item":"https:\/\/allonlinebanglanewspapers.com\/news\/","nextItem":{"@type":"ListItem","@id":"https:\/\/allonlinebanglanewspapers.com\/news\/category\/globenewswire\/#listItem","name":"GlobeNewsWire"}},{"@type":"ListItem","@id":"https:\/\/allonlinebanglanewspapers.com\/news\/category\/globenewswire\/#listItem","position":2,"name":"GlobeNewsWire","item":"https:\/\/allonlinebanglanewspapers.com\/news\/category\/globenewswire\/","nextItem":{"@type":"ListItem","@id":"https:\/\/allonlinebanglanewspapers.com\/news\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\/#listItem","name":"InSitu Biologics Announces Completion of INSB200\u2122 GMP Manufacturing Batch"},"previousItem":{"@type":"ListItem","@id":"https:\/\/allonlinebanglanewspapers.com\/news\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/allonlinebanglanewspapers.com\/news\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\/#listItem","position":3,"name":"InSitu Biologics Announces Completion of INSB200\u2122 GMP Manufacturing Batch","previousItem":{"@type":"ListItem","@id":"https:\/\/allonlinebanglanewspapers.com\/news\/category\/globenewswire\/#listItem","name":"GlobeNewsWire"}}]},{"@type":"Organization","@id":"https:\/\/allonlinebanglanewspapers.com\/news\/#organization","name":"All Online Bangla Newspapers","description":"Daily online newspapers Bangla, Bangla News online, All Bangla Newspaper, All online Bangla news","url":"https:\/\/allonlinebanglanewspapers.com\/news\/","logo":{"@type":"ImageObject","url":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-content\/uploads\/2023\/11\/Daily-Bangla-News.png","@id":"https:\/\/allonlinebanglanewspapers.com\/news\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\/#organizationLogo","width":299,"height":86,"caption":"Daily Bangla News"},"image":{"@id":"https:\/\/allonlinebanglanewspapers.com\/news\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\/#organizationLogo"}},{"@type":"Person","@id":"https:\/\/allonlinebanglanewspapers.com\/news\/author\/giasulhassan\/#author","url":"https:\/\/allonlinebanglanewspapers.com\/news\/author\/giasulhassan\/","name":"Gias Ul Hassan"},{"@type":"WebPage","@id":"https:\/\/allonlinebanglanewspapers.com\/news\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\/#webpage","url":"https:\/\/allonlinebanglanewspapers.com\/news\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\/","name":"InSitu Biologics Announces Completion of INSB200\u2122 GMP Manufacturing Batch","description":"OAKDALE, Minn., Nov. 19, 2026 (GLOBE NEWSWIRE) -- InSitu Biologics, Inc., a life sciences company developing proprietary injectable sustained-release drug-delivery technologies, today announced the successful completion of a Good Manufacturing Practice (GMP) production batch of its lead product candidate, INSB200\u2122. The completed GMP batch will support InSitu\u2019s planned December 2026 submission of an Investigational New","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/allonlinebanglanewspapers.com\/news\/#website"},"breadcrumb":{"@id":"https:\/\/allonlinebanglanewspapers.com\/news\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\/#breadcrumblist"},"author":{"@id":"https:\/\/allonlinebanglanewspapers.com\/news\/author\/giasulhassan\/#author"},"creator":{"@id":"https:\/\/allonlinebanglanewspapers.com\/news\/author\/giasulhassan\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/ml.globenewswire.com\/Resource\/Download\/575a465d-1d3f-4b72-915b-79015161d730","@id":"https:\/\/allonlinebanglanewspapers.com\/news\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\/#mainImage"},"primaryImageOfPage":{"@id":"https:\/\/allonlinebanglanewspapers.com\/news\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\/#mainImage"},"datePublished":"2026-11-19T14:22:07+00:00","dateModified":"2026-11-19T14:22:07+00:00"},{"@type":"WebSite","@id":"https:\/\/allonlinebanglanewspapers.com\/news\/#website","url":"https:\/\/allonlinebanglanewspapers.com\/news\/","name":"All Online Bangla Newspapers","description":"Daily online newspapers Bangla, Bangla News online, All Bangla Newspaper, All online Bangla news","inLanguage":"en-US","publisher":{"@id":"https:\/\/allonlinebanglanewspapers.com\/news\/#organization"}}]},"og:locale":"en_US","og:site_name":"All Online Bangla Newspapers - Daily online newspapers Bangla, Bangla News online, All Bangla Newspaper, All online Bangla news","og:type":"article","og:title":"InSitu Biologics Announces Completion of INSB200\u2122 GMP Manufacturing Batch","og:description":"OAKDALE, Minn., Nov. 19, 2026 (GLOBE NEWSWIRE) -- InSitu Biologics, Inc., a life sciences company developing proprietary injectable sustained-release drug-delivery technologies, today announced the successful completion of a Good Manufacturing Practice (GMP) production batch of its lead product candidate, INSB200\u2122. The completed GMP batch will support InSitu\u2019s planned December 2026 submission of an Investigational New","og:url":"https:\/\/allonlinebanglanewspapers.com\/news\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\/","og:image":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-content\/uploads\/2023\/11\/Daily-Bangla-News.png","og:image:secure_url":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-content\/uploads\/2023\/11\/Daily-Bangla-News.png","og:image:width":299,"og:image:height":86,"article:published_time":"2026-11-19T14:22:07+00:00","article:modified_time":"2026-11-19T14:22:07+00:00","twitter:card":"summary_large_image","twitter:title":"InSitu Biologics Announces Completion of INSB200\u2122 GMP Manufacturing Batch","twitter:description":"OAKDALE, Minn., Nov. 19, 2026 (GLOBE NEWSWIRE) -- InSitu Biologics, Inc., a life sciences company developing proprietary injectable sustained-release drug-delivery technologies, today announced the successful completion of a Good Manufacturing Practice (GMP) production batch of its lead product candidate, INSB200\u2122. The completed GMP batch will support InSitu\u2019s planned December 2026 submission of an Investigational New","twitter:image":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-content\/uploads\/2023\/11\/Daily-Bangla-News.png"},"aioseo_meta_data":[],"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/allonlinebanglanewspapers.com\/news\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/allonlinebanglanewspapers.com\/news\/category\/globenewswire\/\" title=\"GlobeNewsWire\">GlobeNewsWire<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tInSitu Biologics Announces Completion of INSB200\u2122 GMP Manufacturing Batch\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/allonlinebanglanewspapers.com\/news\/"},{"label":"GlobeNewsWire","link":"https:\/\/allonlinebanglanewspapers.com\/news\/category\/globenewswire\/"},{"label":"InSitu Biologics Announces Completion of INSB200\u2122 GMP Manufacturing Batch","link":"https:\/\/allonlinebanglanewspapers.com\/news\/insitu-biologics-announces-completion-of-insb200-gmp-manufacturing-batch\/"}],"_links":{"self":[{"href":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-json\/wp\/v2\/posts\/52917","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-json\/wp\/v2\/comments?post=52917"}],"version-history":[{"count":0,"href":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-json\/wp\/v2\/posts\/52917\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-json\/wp\/v2\/media\/52918"}],"wp:attachment":[{"href":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-json\/wp\/v2\/media?parent=52917"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-json\/wp\/v2\/categories?post=52917"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/allonlinebanglanewspapers.com\/news\/wp-json\/wp\/v2\/tags?post=52917"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}